Surrozen Provides Second Quarter 2024 Financial Results and Business Update
August 12, 2024 16:05 ET
|
Surrozen, Inc.
Surrozen Provides Second Quarter 2024 Financial Results and Business Update
Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting
May 09, 2024 08:30 ET
|
Surrozen, Inc.
Surrozen Presents Data Demonstrating the Promise of Antibody Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at ARVO 2024